BioReference Laboratories, Inc. is the largest full service specialty laboratory in the United States that gives healthcare providers and patients the information to make confident healthcare decisions.
With a focus on genetics, oncology, urology and women’s health, BioReference offers comprehensive test solutions and unparalleled expertise based on a 40 year legacy of proven science. The company is in-network with the largest health plans in the United States, serves approximately 19 million patients annually, operates a network of 10 laboratory locations, and is backed by a medical staff of more than 300 M.D., D.O., Ph.D., genetic counselors and other professional clinical and scientific personnel. With a national footprint and niche market experience, BioReference provides credible and innovative solutions that meet the needs of employers, governmental agencies, educational systems, hospitals and health systems, correctional institutions, sports leagues, travel and leisure industries, and retail markets. BioReference provides industry-leading custom solutions for COVID-19, including point-of-care testing and large-scale screening programs.
Our specialized brands, products and laboratories are a testament to our innovation.
GeneDx Inc. (“GeneDx”), is a global leader in genomics that provides genetic testing to patients and their families. Led by its world-renowned whole exome sequencing program, GeneDx has an acknowledged expertise in rare and ultra-rare genetic disorders, as well as one of the broadest menus of sequencing services available among commercial laboratories. GeneDx offers a suite of genetic testing services, including diagnostic testing for hereditary cancers, inherited cardiac disorders, metabolic disorders, mitochondrial disorders, neurological disorders, and many other conditions.
GenPath Oncology, a division of BioReference, is a leading expert in cancer diagnostics. GenPath offers a comprehensive portfolio to provide a single source solution laboratory for cancer patients’ needs. Backed by a team of specialized pathologists, GenPath delivers a wide range of diagnostic oncology solutions, from routine clinical and special coagulation testing, to complex genomic testing for tumor sequencing and hereditary cancer syndromes. GenPath offers oncologists, pathologists and other healthcare providers testing that includes morphological analysis, immunohistochemistry, FISH, flow cytometry, karyotyping, molecular analysis, and next generation sequencing.
GenPath Urology offers comprehensive tests and services to help diagnose and manage the most difficult cases. GenPath provides urologists with access to a suite of diagnostic testing for a variety of urologic conditions, including prostate cancer, bladder cancer, hereditary cancers, kidney stones, and sexually transmitted infections. GenPath offers the 4Kscore® Test, a blood test that combines four prostate-specific biomarkers with important clinical factors, to provide a man’s risk for aggressive prostate cancer if a biopsy were to be performed, and results should be considered in the shared decision-making process.
GenPath Women’s Health provides expertise as a leading one-source laboratory solution for all testing and service needs for women at every stage of their lives. GenPath offers a comprehensive portfolio that includes cervical cancer screening and biopsies, sexually transmitted and vaginal infection testing, pan-ethnic carrier screening, prenatal screening and diagnosis, advanced prenatal diagnostic testing and hereditary cancer testing. GenPath also offers experienced board-certified genetic counseling, including access to GeneDx and MyGeneTeam.
Scarlet Health® is an in-home, fully integrated digital platform providing access to on-demand specimen collection services. Backed by BioReference’s national presence and infrastructure, with laboratory facilities and professionals across the country, Scarlet delivers an innovative, flexible, mobile alternative to traditional patient service centers or other draw locations when phlebotomy and other specimen collection services are needed.